News
NeuroSphere-supported collaboration to develop new treatments for ALS
Published: 21 June 2021
A new $1.7M collaboration between ±«ÓãÖ±²¥, Raya Therapeutic (Montreal) and (Cambridge, Massachusetts) will enable researchers to conduct clinical trials to assess the efficacy of six different drug candidates for the treatment of Amyotrophic Lateral Sclerosis (ALS).
This new project, led by Thomas Durcan of the Montreal Neurological Institute - Hospital, is funded through a and made possible through contributions from the Ministère de l’Économie et de l’Innovation du Québec (MEI) and from ±«ÓãÖ±²¥'s Healthy Brains, Healthy Lives (HBHL). HBHL contributed $200,000 to the project.
.
